AxoGen(AXGN)
搜索文档
AxoGen(AXGN) - 2019 Q1 - Quarterly Report
2019-05-09 04:14
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to______________ Commission file number: 001-36046 Axogen, Inc. (Exact Name of Registrant as Specified in Its Charter) | --- | ...
AxoGen(AXGN) - 2018 Q4 - Earnings Call Transcript
2019-02-27 10:26
AxoGen, Inc. (NASDAQ:AXGN) Q4 2018 Earnings Conference Call February 26, 2019 4:30 PM ET Company Participants Kaila Krum - Vice President, Investor Relations & Corporate Development Karen Zaderej - Chairman, Chief Executive Officer & President Pete Mariani - Chief Financial Officer Conference Call Participants Richard Newitter - Leerink Raj Denhoy - Jefferies Brian Weinstein - William Blair Sam Brodovsky - BTIG Operator Greetings and welcome to the AxoGen Fourth Quarter 2018 Results Conference Call. At this ...
AxoGen(AXGN) - 2018 Q4 - Annual Report
2019-02-27 05:40
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2018 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from TO Commission File Number: 001-36046 AXOGEN, INC. (Exact name of registrant as specified in its charter) MINNESOTA 41-1301878 (State or other jur ...